Skip to content Skip to footer

Unprecedented Rise: The Emergence of Candida Auris & its Consequences in Hong Kong’s Healthcare Landscape

This study charts the growing incidence and patterns of different Candida species over time. A major focus point is the relationship between C. auris and antifungal prescription and the cascading effects of C. auris-led outbreaks.

The study analyzes data from 43 public hospitals spanning seven healthcare networks in Hong Kong. A staggering 371,653 specimens tested positive for various Candida species out of 206,405 hospitalization episodes involving 150,267 patients. The study breaks down the span of time into two distinct episodes; before and after the emergence of C. auris in Hong Kong.

The study found Candida albicans to be the most predominant species, constituting 57.1% of the isolations. This was trailed by Candida glabrata, Candida tropicalis, and Candida parapsilosis, with C. auris making up 2.0% of all Candida species isolations.

The shocking revelation was that though network A had the highest antifungal prescription, it didn’t experience any outbreaks. Comparatively, networks F and G had 40 hospital outbreaks due to C. auris, pointing at a lack of correlation between antifungal prescription rates and the emergence of C. auris.

The research accentuates the overarching importance of proactive infection control measures to mitigate the nosocomial transmission and recurrent outbreaks of C. auris thoroughly. The authors prescind that understanding Candida species epidemiology, infection control policies, and Candida treatment management would be crucial in effectively managing the spread of C. auris in hospital landscapes.


Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]